您当前所在的位置:首页 > 产品中心 > 产品详细信息
78628-28-1 分子结构
点击图片或这里关闭

({3-[3-(piperidin-1-ylmethyl)phenoxy]propyl}carbamoyl)methyl acetate

ChemBase编号:6406
分子式:C19H28N2O4
平均质量:348.43662
单一同位素质量:348.20490739
SMILES和InChIs

SMILES:
O(c1cc(CN2CCCCC2)ccc1)CCCNC(=O)COC(=O)C
Canonical SMILES:
O=C(COC(=O)C)NCCCOc1cccc(c1)CN1CCCCC1
InChI:
InChI=1S/C19H28N2O4/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23)
InChIKey:
SMTZFNFIKUPEJC-UHFFFAOYSA-N

引用这个纪录

CBID:6406 http://www.chembase.cn/molecule-6406.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
({3-[3-(piperidin-1-ylmethyl)phenoxy]propyl}carbamoyl)methyl acetate
IUPAC传统名
roxatidine
商标名
Roxit
别名
Roxatidine
Aceroxatidine
Roxatidina
Roxatidinum
Pifatidine
Roxatidine acetate
CAS号
78628-28-1
PubChem SID
160969713
PubChem CID
5105

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB08806 external link
PubChem 5105 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 14.8782835  质子受体
质子供体 LogD (pH = 5.5) -1.7924889 
LogD (pH = 7.4) -0.12762822  Log P 1.3130374 
摩尔折射率 96.3186 cm3 极化性 37.719524 Å3
极化表面积 67.87 Å2 可自由旋转的化学键 10 
里宾斯基五规则 true 
Log P 2.27  LOG S -3.76 
溶解度 6.12e-02 g/l 

分子性质

分子性质

生物活性(PubChem)

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB08806 external link
Item Information
Drug Groups approved
Description Roxatidine acetate is a specific and competitive H2 receptor antagonist. It is currently approved in South Africa under the tradename Roxit.
Indication For the treatment of disorders of the upper gastro-intestinal region that are due to an excess of hydrochloric acid in the gastric juice, i.e. duodenal ulcers, benign gastric ulcers. Also for prophylaxis of recurrent gastric and duodenal ulcers
Pharmacology Roxatidine acetate suppresses the effect of histamine on the parietal cells of the stomach (H2-receptor antagonist). This suppressive action is dose-dependent. As a result, the production and secretion, particularly of gastric acid, are reduced. Roxatidine acetate has no antiandrogenic effects and does not influence drug-metabolizing enzymes in the liver.
Toxicity Oral, mouse LD50: 1000 mg/kg
Affected Organisms
Humans and other mammals
Biotransformation Roxatidine acetate is rapidly metabolised to the primary, active desacetyl metabolite.
Absorption Well absorbed orally (80–90% bioavailability).
Half Life 5-6 hours
Protein Binding 5-7%
References
[Product Insert]
External Links
Wikipedia

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle